Scientific Sessions

• Epidemiology and Drivers of the Opioid and Drug Abuse Crisis
• Neurobiology of Opioid Dependence and Overdose Risk
• Medication-Assisted Treatment (MAT) and Clinical Management
• Harm Reduction Strategies and Public Health Interventions
• Policy, Ethics, and Stigma in Substance Use Care
• Community-Based Recovery and Continuum of Care

Drug Abuse, Opioid Crisis and Harm Reduction addresses one of the most urgent public health challenges of our time. This session examines the scope and drivers of substance misuse, with a focused lens on opioids, polysubstance use, and overdose mortality. Participants will explore the neurobiological mechanisms of opioid dependence, tolerance, and withdrawal, alongside social determinants such as pain management practices, illicit drug markets, socioeconomic vulnerability, and trauma. Emphasis is placed on surveillance data, risk assessment, and early intervention strategies that inform prevention and clinical decision-making. As a key track within leading addiction and psychiatry conferences, this session integrates neuroscience, epidemiology, and health systems research to contextualize the crisis across diverse regions and populations.

The session at addiction and psychiatry conferences further highlights evidence-based responses, including medication-assisted treatment (MAT), overdose prevention, and harm reduction models that prioritize safety, dignity, and access to care. Topics include the use of opioid agonist and antagonist therapies, naloxone distribution, syringe services, supervised consumption approaches, and drug checking technologies. Experts will discuss integrating harm reduction with mental health services, addressing co-occurring psychiatric disorders, and improving care transitions from emergency and correctional settings. Policy frameworks, ethical considerations, and stigma reduction strategies are examined to support scalable, community-centered solutions. Recovery-oriented systems of care, peer-led interventions, and digital tools for monitoring and engagement are also explored. Designed for clinicians, researchers, policymakers, and public health professionals attending global addiction and mental health conferences, this session provides practical, data-driven insights to reduce overdose deaths, improve treatment retention, and advance compassionate, effective responses to drug abuse and the opioid crisis.

Key Highlights

• Current trends and drivers of the opioid and drug abuse crisis
• Neurobiology of opioid dependence and overdose prevention
• Medication-assisted treatment and integrated clinical care
• Harm reduction strategies and public health best practices
• Policy, ethics, stigma reduction, and community recovery

Why This Session Is Important?

This session is critical for translating evidence into action during a global substance use emergency. By uniting clinical care, harm reduction, and policy perspectives, it equips professionals to reduce overdose deaths, expand access to treatment, and build humane, effective systems of care that save lives and support long-term recovery.